Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 AlteredExpression disease BEFREE Collectively, our results indicate that PEDF expression has a significant impact on oxidative and inflammatory properties of ChECs, whose alteration could contribute to pathogenesis of chronic inflammatory diseases including exudative AMD. 29351407 2018
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE The goal of the present study was the development of an efficient and safe technique to integrate, ex vivo, the PEDF gene into retinal pigment epithelial (RPE) cells for later transplantation to the subretinal space of AMD patients to allow continuous PEDF secretion in the vicinity of the affected macula. 29858090 2018
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease BEFREE The T-C haplotype frequency of rs1136287-rs1894286 in PEDF were significantly correlated to the increased susceptibility to AMD (OR = 1.57, 95% CI = 1.02-2.40).The rs1136287 polymorphism in PEDF may be related to the occurrence risk of AMD. 30142832 2018
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE Proliferative diabetic retinopathy is the most intensively studied stage of DR. Proteomic studies have established VEGF, pigment epithelium-derived factor (PEDF) and complement components as key factors associated with AMD. 28452939 2017
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE Here, we will discuss the important role of thrombospondins and pigment epithelium-derived factor, two major endogenous inhibitors of angiogenesis, in retinal and choroidal vascular homeostasis and their potential alterations during AMD and choroidal neovascularization (CNV). 28679845 2017
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE Since the wet form of age-related macular degeneration is characterized by choroidal neovascularization (CNV), PEDF would be an ideal candidate to inhibit CNV and support retinal pigment epithelial (RPE) cells. 26697494 2015
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease BEFREE Four PEDF polymorphisms were meta-analyzed: rs1136287, rs12150053, rs12948385 and rs9913583, but none was significantly associated with AMD or PCV. 25820866 2015
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE Further studies of comprehensive PEDF gene variations are required to characterize the susceptibility of PEDF gene in the pathogenesis of AMD. 21174599 2011
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease BEFREE To determine whether there is an association between complement factor H (CFH), high-temperature requirement A-1 (HTRA1), vascular endothelial growth factor (VEGF), and pigment epithelium-derived factor (PEDF) genotypes and response to treatment with photodynamic therapy (PDT) for age-related macular degeneration (AMD) in a Japanese population. 20678803 2011
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 AlteredExpression disease BEFREE Here we showed that retinopathy in OXYS rats is similar to human AMD according to clinical signs, morphology, and vascular endothelium growth factor (VEGF) and pigment epithelium-derived factor (PEDF) genes expression. 21191149 2011
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 AlteredExpression disease BEFREE VEGF protein expression was increased and PEDF protein expression was decreased in RPE from smoker patients with AMD versus controls resulting in increased VEGF/PEDF ratio. 21386905 2011
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE These data demonstrate that brief subretinal administration of SeV-F/HN-SIV vectors may facilitate safe and efficient retinal gene transfer, and suggest the therapeutic potential of PEDF with a higher safety profile for treating CNV in AMD patients. 19778186 2010
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease LHGDN PEDF genotype and allele frequencies were not significantly different between AMD patients and control subjects. 19223990 2009
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease BEFREE The aim of this study was to validate the previously reported association of the PEDF Met72Thr variant in a well characterized Japanese population with neovascular AMD and PCV. 19503741 2009
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE PEDF may play a role in the pathogenesis of wet AMD. 18226801 2008
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 GeneticVariation disease BEFREE Since it is well known that a single nucleotide polymorphism and resultant amino acid change often alters the activity or expression level of the target protein, we would like to propose here a novel hypothesis that the Met72Thr polymorphism (T/C polymorphism) of PEDF gene may be a genetic marker for ARMD. 15823717 2005
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE The primary objectives of this investigation are: (1) to assess the safety, tolerability and feasibility of intravitreal injection of Ad(GV)PEDF.11D in patients with severe, neovascular AMD, (2) to identify the maximum tolerated dose (MTD) of Ad(GV)PEDF.11D, and (3) to get some indication of potential activity of Ad(GV)PEDF.11D. 11727737 2001
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.100 Biomarker disease BEFREE Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. 11748590 2001